BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1816058)

  • 1. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia.
    Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF
    Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
    Osterholz J; Dowding C; Guo AP; Siczkowski M; Goldman JM
    Exp Hematol; 1991 Jun; 19(5):326-31. PubMed ID: 2026184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell growth and blast colony-forming cells in AML bone marrow.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Leuk Res; 1991; 15(11):1037-41. PubMed ID: 1961007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
    Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases].
    Tassies D; Feliu E; Villamor N; Urbano-Ispizua A; Cervantes F; Campo E; Ordi J; Vernet M; Pujol R; López R
    Med Clin (Barc); 1990 Nov; 95(16):618-20. PubMed ID: 2097454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
    Gidáli J; Fehér I; Hollán SR
    Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
    Konaka Y; Namiuchi S
    Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
    Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
    Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
    Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.